Microbiology

Precision. Compliance. Trust.

Our capabilities

Modern manufacturing environments demand microbiology systems that provide confidence, clarity, and control. As products, processes, and regulatory expectations grow more complex, contamination control risk increases – and teams require a microbiology function that is structured, predictable, and tightly aligned to quality and operations.

Our approach brings the same discipline and governance found in high performing programme environments into the microbiology space, ensuring that monitoring, utilities, release testing, ID, and investigations operate with consistency and transparency.

When contamination control becomes critical, our structured microbiology framework eliminates uncertainty

A Comprehensive Control Framework

Environmental and utilities related risks often emerge because sampling strategies, alert/action limits, or trending models are unclear or inconsistently applied. To prevent this, we operate a comprehensive, risk based contamination control framework spanning multiple ISO class clean rooms (7, 8 and 9), utilities microbiology, and media verification.

An environmental monitoring programme with graded frequencies, excursion workflows, and trend driven reviews

Utilities microbiology for pure water and compressed air to confirm utilities never become contamination sources

Growth promotion testing to verify media performance so negative results remain trustworthy

Integrated data integrity controls across sampling, incubation, and reporting

This structured approach reduces rework, prevents late contamination surprises, and provides consistent visibility into the state of the environment and utilities.

When sterility assurance is essential, we apply validated methods that ensure products meet microbiological release requirements

Bioburden, Endotoxin and Dose Verification Control

Product release risk increases when bioburden, dose verification, or endotoxin processes are not standardised or managed proactively. To maintain sterility assurance and protect patient safety, we run tightly controlled release critical microbiology methods.

Presterilisation bioburden testing and routine dose audits to validate lethality

Kinetic chromogenic LAL for endotoxin compliance aligned with harmonised pharmacopeia

Controlled incubation logistics to ensure on time release

Clear, structured reporting (CFU/device, CFU/mL, EU/mL, CoAready outputs)

This consistently reduces Out Of Specification (OOS) events, avoids recall level failures, and compresses release cycle time through efficient validated workflows.

When investigations demand clarity, we deliver organism identification and microbiology driven root cause analysis that strengthen CAPA

Comprehensive Investigation Support

Unclear organism sources or incomplete microbiology investigations can prolong deviations and weaken CAPAs. To address this, we support deviations and complaints with a disciplined root cause approach grounded in organism identification and risk assessment.

MALDITOF identification to achieve species level clarity in <5 days

Organism tracking across the environment, utilities, in process, and complaint samples

Integration of microbiological findings directly into CAPA and risk assessments

Retention and curation of isolates for trend mapping and “resident flora” profiling

This approach shortens investigation timelines, provides objective evidence for CAPA decisions, and strengthens long-term contamination control strategy.

When methods must be reliable across sites and products, we validate, verify, and transfer microbiology methods with regulatory discipline

Consistently Applied Methods

Method failures often occur when verifications, transfers, or validations lack systematic structure. To prevent this, we apply a rigorous, phase aligned methodology for compendial verification and alternative method validation.

Full method development, validation, and transfer

Verification of standard methods to ensure fitness for purpose (LOD, LOQ, accuracy, robustness)

Right first time transfer approaches that reduce OOS and repeat testing

Parallel drafting of protocols and reports to accelerate readiness

This reduces late stage churn, improves consistency across sites, and ensures that every method deployed is reliable, compliant, and efficient.

When operational robustness is required, we support teams with cross training, equipment readiness, and controlled microbiology infrastructure

Operationally Aligned Support

Microbiology throughput slows when teams lack flexibility, or when equipment, incubation, or analytical systems are not aligned with operational demand. To maintain reliability, we invest in capability depth and controlled infrastructure.

Cross training across environment, utilities, release testing, and investigations to reduce bottlenecks

Incubators spanning 20–25 °C, 30–35 °C, and 2–8 °C

Grade A BSCs/isolators, ISO class cleanrooms for sterility testing, and validated autoclave cycles

Active air samplers, non viable particle counters, LAL readers, and validated supporting equipment

This enables consistent turnaround time, stable capacity, and confidence that testing stays aligned with production needs.

Why choose Quvara microbiology?

Because we don’t simply test – we bring structure, risk control, and predictable performance to the microbiology function.
We integrate contamination control strategy, method reliability, sterility assurance, investigation clarity, and operational readiness into a single, dependable system that gives teams:

Our microbiology capability ensures quality, compliance, and dependable testing performance — every time.

Clear visibility of contamination risks

Predictable and ontime release outcomes

Faster, evidence based investigations

Reliable validation and method transfer

A collaborative partner who removes uncertainty

Need more information on our Microbiology Testing?

If you are developing, scaling, or manufacturing a regulated medical device, unanswered questions slow everything down.

Ask a Question